EdU assays further verified that the proliferative abilities of SW620 and SW48 cells were significantly suppressed by Remodelin (Fig. 2D), suggesting that Remodelin treatment inhibits the proliferation of CRC cells expressing wild-type or mutant KRAS. The gene discussed is KRAS; the disease is colorectal carcinoma.